Gold in innovative science and technology markets, industrial, medical and dental uses. Training and development news

www.science.gold.org

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Gold nanoparticles 'could aid breast cancer treatment' > Gold News > World Gold Council, gold and science, industrial, technological and medical applications

 

Gold nanoparticles 'could aid breast cancer treatment'

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Thursday, 12th March 2009 (1653 views)

Scientists at Brown University have developed a new gold nanoparticle that could help to treat breast cancer, it has been claimed.

A twin nanoparticle formed by combining the precious metal with iron oxide may enable cancer fighting drugs to be delivered into the human body without the side effects of medications administered during chemotherapy, Nanowerk News reports.

Shouheng Sun, a chemistry professor at the university, told the news source that the aim of the technology is to target tumour cells while ignoring the healthy ones.

"Like a missile, you don't want the anti-cancer drugs to explode everywhere," he was quoted as saying.

The technique has destroyed affected cells in up to 80 per cent of cases during laboratory tests and scientists also hope to be able to develop nanoparticles that can release the drug remotely through the use of magnetic heating.

This is the latest breakthrough in the area of using nanotechnology to treat medical conditions.

Earlier this week, Science Daily revealed that a new nanotechnology coating for brain implants could help treat paralysis and Parkinson's disease.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Search our Gold Science & Technology content.

  • Gold Spot Price
  • Bid: $1167.40
  • Ask: $1168.20
  • Last Update: 05:39 GMT
© 2009 World Gold Council - all rights reserved. Produced and managed by CFP Group.